154 results on '"Barbarino, Marcella"'
Search Results
2. Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma
3. MicroRNA as Possible Mediators of the Synergistic Effect of Celecoxib and Glucosamine Sulfate in Human Osteoarthritic Chondrocyte Exposed to IL-1β
4. Supplementary Data from Metabolic Approach to the Enhancement of Antitumor Effect of Chemotherapy: a Key Role of Acetyl-l-Carnitine
5. Analysis of Primary Cilium Expression and Hedgehog Pathway Activation in Mesothelioma Throws Back Its Complex Biology
6. TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration
7. A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma
8. Isoxazolo(aza)naphthoquinones: A new class of cytotoxic Hsp90 inhibitors
9. Efficient organic monoliths prepared by γ-radiation induced polymerization in the evaluation of histone deacetylase inhibitors by capillary(nano)-high performance liquid chromatography and ion trap mass spectrometry
10. Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms
11. CDK4, CDK6/cyclin-D1 Complex Inhibition and Radiotherapy for Cancer Control: A Role for Autophagy
12. Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors
13. PRIMARY CILIUM LOSS IN ADVANCED MESOTHELIOMA CORRELATES WITH CONSTITUTIVE GLI1 OVEREXPRESSION
14. A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma.
15. Assessment of the Carcinogenicity of Carbon Nanotubes in the Respiratory System
16. Exploring the Crosstalk between Hydrostatic Pressure and Adipokines: An In Vitro Study on Human Osteoarthritic Chondrocytes
17. Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma
18. EIF4G1 and RAN as Possible Drivers for Malignant Pleural Mesothelioma
19. Hydrostatic Pressure Regulates Oxidative Stress through microRNA in Human Osteoarthritic Chondrocytes
20. PRMT5 silencing selectively affects MTAP ‐deleted mesothelioma: In vitro evidence of a novel promising approach
21. Tumour Treating Fields for mesothelioma
22. CRH Inhibits Cell Growth of Human Endometrial Adenocarcinoma Cells via CRH-Receptor 1-Mediated Activation of cAMP-PKA Pathway
23. Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma.
24. MicroRNA-34a and MicroRNA-181a Mediate Visfatin-Induced Apoptosis and Oxidative Stress via NF-κB Pathway in Human Osteoarthritic Chondrocytes
25. Nanoparticle‐biomolecular corona: A new approach for the early detection of non‐small‐cell lung cancer
26. Publisher Correction: TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration
27. Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre‐clinical assessment
28. Effects of antioxidants on apoptosis induced by dasatinib and nilotinib in K562 cells
29. New molecular targets for the treatment of neovascular age-related macular degeneration
30. Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs
31. Bilateral Lacrimal Gland Mantle Cell Lymphoma: A Case Report and Review of the Literature
32. Anti-cancer activity of dose-fractioned mPE +/− bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients
33. P2.03a-053 Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab
34. P2.05-057 Baseline Inflammatory and Immunological Profile Predict the Survival of NSCLC Patients Undergone Palliative Radiotherapy
35. Nanoparticle‐biomolecular corona: A new approach for the early detection of non‐small‐cell lung cancer.
36. Novel PARP-1 inhibitors based on a 2-propanoyl-3H-quinazolin-4-one scaffold
37. ST7612AA1, a Thioacetate-ω(γ-lactam carboxamide) Derivative Selected from a Novel Generation of Oral HDAC Inhibitors
38. Abstract 5556: Mice models of three human mesothelioma histotypes derived from primary patient tumors
39. Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs.
40. Synthesis and Evaluation of New Hsp90 Inhibitors Based on a 1,4,5-Trisubstituted 1,2,3-Triazole Scaffold
41. Abstract 1012: Pan HDACs inhibitor ST3595 targets PARP activity and has curative effect in breast BRCA-deficient model when combined with cisplatin treatment.
42. Abstract 1010: New thiol-ω(γ-lactam amide) SAHA analogues as potent histone deacetylase (HDAC) inhibitors..
43. Abstract 1774: Dihydroartemisinin (DHA): A potent enhancer of PARP inhibitors and DNA-damaging agents activity in human tumor models
44. Abstract 3896: New heat shock protein 90 inhibitors based on the 1,2,3-triazole structure
45. Erratum to “Efficient organic monoliths prepared by γ-radiation induced polymerization in the evaluation of histone deacetylase inhibitors by capillary(nano)-high performance liquid chromatography and ion trap mass spectrometry” [J. Chromatogr. A 1218 (2011) 3862–3875]
46. Novel 3,4-Isoxazolediamides as Potent Inhibitors of Chaperone Heat Shock Protein 90
47. Abstract 2623: ST3595, a new histone deacetylase (HDAC) inhibitor endowed with a peculiar mechanism of action
48. Metabolic Approach to the Enhancement of Antitumor Effect of Chemotherapy: a Key Role of Acetyl-l-Carnitine
49. Abstract 566: Interaction of acetyl-L-carnitine with platinum compounds: A possible role of protein acetylation in modulation of antitumor activity
50. ω-Alkoxy analogues of SAHA (vorinostat) as inhibitors of HDAC: A study of chain-length and stereochemical dependence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.